TriSalus Life Sciences Announces Chief Financial Officer Transition With Appointment of David B. Patience

David Patience, an accomplished healthcare CFO with deep experience in the life sciences sector, appointed as CFO effective July 1, 2025 Current CFO James E. Young steps down; Dan Giordano, Vice President of Finance, to serve as acting CFO during transition period DENVER–(BUSINESS WIRE)–TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the “Company”), an oncology company integrating … [Read more…]

Iksuda Therapeutics announces first patient successfully dosed in phase 1 trial evaluating IKS03 in advanced B cell non-Hodgkin lymphomas

First-in-human trial is designed to determine recommended dose of IKS03, a CD19-directed antibody drug conjugate, for the subsequent dose-expansion IKS03 is Iksuda’s second asset to begin clinical testing NEWCASTLE, England–(BUSINESS WIRE)–Iksuda Therapeutics (Iksuda), the developer of class-leading antibody drug conjugates (ADCs) with clinically validated tumour-selective payload release formats, today announces the completion of dosing of … [Read more…]

Genentech’s Fenebrutinib Maintains Near-Complete Suppression of Disease Activity and Disability Progression for up to Two Years in People With Relapsing Multiple Sclerosis

– Patients on fenebrutinib had low relapse rates with data showing no active brain lesions or disability progression after nearly two years of treatment – – Phase III studies for fenebrutinib in relapsing and primary progressive multiple sclerosis are expected to start reading out at year end – SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member … [Read more…]

Cellares and Mitsui Fudosan Announce the First IDMO Smart Factory for Commercial-Scale Cell Therapy Manufacturing in Japan

Integrated, automated facility will unlock next-generation, commercial-scale cell therapy manufacturing in Japan IDMO Smart Factory manufacturing capabilities will accelerate patient access for CAR-T and other cell therapies in the region SOUTH SAN FRANCISCO, Calif. & TOKYO–(BUSINESS WIRE)–Cellares, a pioneer in automated cell therapy manufacturing, in collaboration with Mitsui Fudosan, announces the establishment of Japan’s first … [Read more…]

Experienced Lender Joins Menlo Dental Transitions as Practice Advisor for the Southeast

TEMPE, Ariz.–(BUSINESS WIRE)–#DentalTransitions–Menlo Dental Transitions is pleased to announce that Matt Adrian has joined the company as a Practice Advisor, where he will support dental practice owners throughout the Southeast. Adrian brings more than 25 years of experience in the dental lending industry, having funded nearly $2 billion in loan volume and guided hundreds of … [Read more…]

RevBio Expands Globally into the United Kingdom with its Second Cranial Flap Fixation Clinical Trial for its Regenerative Bone Adhesive

This Clinical Trial will Demonstrate the Use of TETRANITE® to Reintegrate Cranial Bone Flaps for Improved Clinical Outcomes LOWELL, Mass.–(BUSINESS WIRE)–#BoneRepair–RevBio, Inc., announced that it has received approval from the Medicines and Health Regulatory Agency (MHRA) to conduct a 15 patient pilot clinical trial to use TETRANITE® to reintegrate bone flaps, which are portions of … [Read more…]

Vivodyne to Replace Animal Testing With $40 Million Funding to Reverse 95% Clinical Trial Failure Rate

95% of clinical trials fail because animal testing is no substitute for human biology – Vivodyne’s robotics platform grows thousands of human tissues daily, directly tackling the biological gap behind clinical failures. Vivodyne’s AI generates clinically predictive human datasets, already in use by most of the world’s top pharmaceutical firms. Series A, led by Khosla … [Read more…]

AN2 Therapeutics Announces Poster Presentation Highlighting M. Abscessus Data at 2025 Colorado Mycobacteria Conference

Epetraborole’s potent activity against M. abscessus supports further investigation as a potential therapy for disease with an estimated all-cause mortality of 45% MENLO PARK, Calif.–(BUSINESS WIRE)–AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today announced that the company will present … [Read more…]

Diagnostics.ai Launches Industry’s First CE-IVDR Certified Transparent AI Platform for Molecular Diagnostics as Regulatory Deadlines take Effect

CE-marked under the EU IVDR regulation, Diagnostics.ai’s platform is the first to deliver algorithmic transparency and per-test auditability for clinical PCR diagnostics LONDON–(BUSINESS WIRE)–#AI—Revolutionary Platform Sets New Benchmark for Transparency and Compliance in Diagnostic AI As the May 26th CE-IVDR compliance deadline comes into effect, Diagnostics.ai launches the industry’s first fully-transparent machine learning platform for … [Read more…]

AHF Poland Joins Calls for Period Equity on Menstrual Health Day

LUBLIN, Poland–(BUSINESS WIRE)–#EndPeriodPoverty–Join AIDS Healthcare Foundation (AHF) Poland for a Menstrual Health Day commemorative event at the Center for Culture on Saturday, May 31, 2025, at 16.00 to address the stigma, cultural taboos, and lack of menstrual hygiene access that undermine dignity and increase HIV risk among women and girls/people who menstruate. Menstrual Health Day … [Read more…]